SPC Samlip Co., Ltd. (KRX:005610)
50,300
+700 (1.41%)
Mar 10, 2026, 9:10 AM KST
SPC Samlip Revenue
SPC Samlip had revenue of 863.08B KRW in the quarter ending September 30, 2025, with 2.12% growth. This brings the company's revenue in the last twelve months to 3.40T, up 0.05% year-over-year. In the year 2024, SPC Samlip had annual revenue of 3.43T, down -0.16%.
Revenue (ttm)
3,404.12B
Revenue Growth
+0.05%
P/S Ratio
0.12
Revenue / Employee
1.22B
Employees
2,791
Market Cap
402.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3,427.92B | -5.40B | -0.16% |
| Dec 31, 2023 | 3,433.32B | 118.78B | 3.58% |
| Dec 31, 2022 | 3,314.55B | 367.89B | 12.49% |
| Dec 31, 2021 | 2,946.65B | 403.94B | 15.89% |
| Dec 31, 2020 | 2,542.71B | 43.47B | 1.74% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EASY HOLDINGS | 3,385.10B |
| Nongshim Holdings | 802.99B |
| Pulmuone Corporate | 3,338.70B |
| Samyang | 2,604.05B |
| Namyang Dairy Products | 916.64B |
| Daesang Holdings | 5,623.06B |
| Kwang Dong Pharmaceutical | 1,638.24B |
| Sajodaerim | 3,478.58B |